ES2104889T3 - Derivado de 6-o-metileritromicina a. - Google Patents

Derivado de 6-o-metileritromicina a.

Info

Publication number
ES2104889T3
ES2104889T3 ES92902490T ES92902490T ES2104889T3 ES 2104889 T3 ES2104889 T3 ES 2104889T3 ES 92902490 T ES92902490 T ES 92902490T ES 92902490 T ES92902490 T ES 92902490T ES 2104889 T3 ES2104889 T3 ES 2104889T3
Authority
ES
Spain
Prior art keywords
derivative
activity against
methylerithromycin
bacteria
powerful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92902490T
Other languages
English (en)
Inventor
Masato Raionzugahden Kashimura
Toshifumi Asaka
Shigeo Morimoto
Katsuo Horisakichodan Hatayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2104889T3 publication Critical patent/ES2104889T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN DERIVADO DE 6-O-METILERITROMICINA A REPRESENTADO POR LA FORMULA GENERAL (I) Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO QUE TIENE UNA POTENTE ACTIVIDAD ANTIBACTERIANA CONTRA LA BACTERIA GRAM-NEGATIVA Y UNA ACTIVIDAD AUN MAS POTENTE CONTRA LA BACTERIA GRAM-POSITIVA QUE LA DE LOS COMPUESTOS CONOCIDOS. EN DICHA FORMULA R1 Y R2 REPRESENTAN CADA UNO HIDROGENO O ALQUILO C1 A C3 Y A REPRESENTA NITROGENO O N -> O.
ES92902490T 1990-11-28 1991-11-22 Derivado de 6-o-metileritromicina a. Expired - Lifetime ES2104889T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32652990 1990-11-28

Publications (1)

Publication Number Publication Date
ES2104889T3 true ES2104889T3 (es) 1997-10-16

Family

ID=18188854

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92902490T Expired - Lifetime ES2104889T3 (es) 1990-11-28 1991-11-22 Derivado de 6-o-metileritromicina a.

Country Status (8)

Country Link
US (1) US5403923A (es)
EP (1) EP0559896B1 (es)
KR (1) KR0166096B1 (es)
AT (1) ATE157368T1 (es)
CA (1) CA2096969C (es)
DE (1) DE69127457T2 (es)
ES (1) ES2104889T3 (es)
WO (1) WO1992009614A1 (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69301916T2 (de) * 1992-04-22 1996-08-08 Taisho Pharmaceutical Co., Ltd., Tokio/Tokyo 5-0-desosaminylerythronolid a derivate
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2707088B1 (fr) * 1993-07-02 1995-08-25 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697523B1 (fr) * 1992-11-05 1994-12-02 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
EP0876388B1 (en) * 1995-11-08 2004-02-18 Abbott Laboratories Tricyclic erythromycin derivatives
US5747466A (en) * 1995-11-08 1998-05-05 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
ATE296831T1 (de) * 1996-09-04 2005-06-15 Abbott Lab 6-0-substituierte ketoliden mit antibakteriellen wirkung
US5804565A (en) * 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
US6162794A (en) * 1997-05-09 2000-12-19 Pfizer Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6124269A (en) * 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
US6046171A (en) * 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
PT952157E (pt) 1998-04-24 2003-11-28 Pfizer Prod Inc Derivados 9a, 11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina
US6020521A (en) * 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6355620B1 (en) 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
US6420535B1 (en) 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
US6627743B1 (en) * 1999-12-03 2003-09-30 Abbott Laboratories 6-O-methylerythromycin A crystal form III
KR20030011797A (ko) * 2000-03-28 2003-02-11 바이오케미 게젤샤프트 엠베하 맛이 차폐된 과립형 입자
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20030069332A1 (en) * 2001-09-14 2003-04-10 Giorgio Agostini Prepared elastomer/reinforcing filler composite and tire having component thereof
US6878760B2 (en) * 2001-09-14 2005-04-12 The Goodyear Tire & Rubber Company Preparation of starch reinforced rubber and use thereof in tires
US6838511B2 (en) * 2001-10-11 2005-01-04 The Goodyear Tire & Rubber Company Tire with configured rubber sidewall designed to be ground-contacting reinforced with carbon black, starch and silica
US20030092801A1 (en) * 2001-11-15 2003-05-15 Giorgio Agostini Rubber composition comprised of functionalized elastomer and starch composite with coupling agent and tire having at least one component thereof
US20030096900A1 (en) * 2001-11-16 2003-05-22 Holden Brian David Organic plant derived precipitated silica aggregates, elastomers reinforced therewith and articles such as tires with component thereof
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
KR100661973B1 (ko) * 2002-05-13 2006-12-28 이난타 파마슈티칼스, 인코포레이티드 6,11 바이사이클릭 에리스로마이신 유도체
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
WO2005070918A1 (en) * 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US6812216B2 (en) * 2002-06-25 2004-11-02 Enanta Pharmaceuticals, Inc. 11-C-substituted derivatives of clarithromycin
US6750204B2 (en) 2002-06-25 2004-06-15 Enanta Pharmaceuticals, Inc. 11-C-substituted ketolides
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US7276487B2 (en) * 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US20050145312A1 (en) * 2003-12-18 2005-07-07 Herberger James R.Sr. Tire component, and tire with such component, of rubber composition which contains combination of soybean oil and starch/plasticizer composite
US6953782B2 (en) * 2003-12-24 2005-10-11 Enanta Pharmaceuticals, Inc. 11-C-substituted erythromycin derivatives
US7414030B2 (en) * 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
US7265094B2 (en) * 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
US7229972B2 (en) 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
US7419962B2 (en) 2004-12-07 2008-09-02 Enanta Pharmaceuticals, Inc. 3,6-bicyclolides
TW200635600A (en) 2004-12-13 2006-10-16 Enanta Pharm Inc Tetracyclic bicyclolides
WO2006065721A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
EP2203435B1 (en) * 2007-09-17 2018-07-18 Enanta Pharmaceuticals, Inc. 6, 11-bridged biaryl macrolides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
GB8729369D0 (en) * 1987-12-16 1988-01-27 Beecham Group Plc Chemical compounds
JP2782793B2 (ja) * 1988-06-15 1998-08-06 大正製薬株式会社 エリスロマイシンａ誘導体およびその製造方法

Also Published As

Publication number Publication date
EP0559896A4 (en) 1993-10-27
KR0166096B1 (ko) 1999-01-15
DE69127457D1 (en) 1997-10-02
CA2096969A1 (en) 1992-05-29
WO1992009614A1 (en) 1992-06-11
DE69127457T2 (de) 1998-01-22
ATE157368T1 (de) 1997-09-15
CA2096969C (en) 2000-11-21
US5403923A (en) 1995-04-04
EP0559896A1 (en) 1993-09-15
EP0559896B1 (en) 1997-08-27

Similar Documents

Publication Publication Date Title
ES2104889T3 (es) Derivado de 6-o-metileritromicina a.
ES2188584T3 (es) Derivados heterociclicos de amina.
ES2146741T3 (es) Derivados de rapamicina utiles como inmunosupresores.
ES2071510T3 (es) Derivados de pirrolidina y de tiazolidina, su preparacion y los medicamentos que les contienen.
CO4290420A1 (es) Derivados antitromboticos de amidinofenilalanina y amidino- piridilalanina
MX9602837A (es) Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados.
ES2171416T3 (es) Remedio contra la trombocitopenia.
ES2110070T3 (es) Derivados alquilamino ramificados del tiazol, procedimientos para su obtencion y composiciones farmaceuticas que los contienen.
FR2698543B1 (fr) Nouvelles compositions à base de taxoides.
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
IT7822478A0 (it) Purificazione di una soluzione acquosa di cloruro di sodio.
MX9203385A (es) Derivados de taxol y composiciones farmaceuticas que los contienen.
CO4940451A1 (es) Derivados de acido barbiturico con actividad antimetastica y antitumoral
ES2057959T3 (es) Derivados de tienopiridina y composiciones farmaceuticas que los contienen.
ES2109993T3 (es) Derivados de 4-desoxi-4-epipodofilotoxina o sus sales farmaceuticamente aceptables.
ES2095976T3 (es) Compuestos de pirazolopiridina y procedimiento para su preparacion.
ES2039230T3 (es) Procedimiento para preparar antibioticos glicopeptidicos.
AR007997A1 (es) Un derivado de distamicina sustituida con acriloilo, sus utilizaciones, un procedimiento para producirlo y una composicion farmaceutica que lo comprende.
CO4520229A1 (es) Derivados de la oxazolidin-2-ona y procedimiento para su obtencion
AR012946A1 (es) Forma cristalina a de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida, preparaciones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
AR240814A2 (es) Nuevos derivados de acilamino-s-triazina, procedimiento para su preparacion y composiciones antiparasitarias que los contienen, excluida su actividad terapeutica.
ES2072386T3 (es) Derivados del penciclovir para el tratamiento de las infecciones de hepatitis-b.
ES2077891T3 (es) Empleo de oximeter derivados para la biorregulacion de las plantas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 559896

Country of ref document: ES